Prepared by richstorm.co • April 2026 Executive Summary This report provides a comprehensive investment analysis of eight leading global pharmaceutical companies as of April 24, 2026. Each company has been evaluated across six investment factors: Pipeline Strength, Financial Health, Growth Momentum, Valuation, Patent Cliff Risk, and Analyst Sentiment. Final verdicts are BUY, HOLD, or SELL. INVESTMENT VERDICTS AT A GLANCE Key observations from this analysis: BUY cand